Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19 By: MarketWatch April 17, 2020 at 06:09 AM EDT “Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI. Read More >> Related Stocks: Berkshire Hathaway Boeing Co Dr. Reddy's Laboratories Ltd ADR Gilead Sciences